Русский / English
Enter the query
News
Press Center
phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru
Contacts
Topics
Norilsk Nickel
Calendar
prev next July 2022
Mon Tue Wed Thu Fri Sat Sun
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31
Actual
09.04.2021
Interros, VEB.RF and Vasta Discovery agree to build a new all-season resort in Sochi
Building on the success of Rosa Khutor resort, the $1 bln project will bring quality hotels and rehabilitation facilities, new skiing tracks for over a million of visitors per year while creating thousands of new jobs More Topics Interros / VEB.RF / Vasta Discovery / Sochi
22.07.2020
International Clinical Trial Of Polyoxidonium Confirms Its Safety For Covid-19 Treatment
A Russian original medication called Polyoxidonium® by Petrovax, a pharmaceutical company affiliated to the Interros Group, has passed the first phase of an international clinical trial for its effectiveness and safety for COVID-19 treatment.
More Topics Petrovax Pharm
17.04.2020
Petrovax to Test Polyoxidonium for Covid-19 Treatment in an International Clinical Trial
Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax-  was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.
More Topics Petrovax Pharm
23.03.2020
Vladimir Potanin donates one billion rubles to support the non-profit sector in times of global instability
The Foundation is now announcing the launch of new large-scale initiatives to help non-profits and their beneficiaries to survive the next few months
More Topics COVID-19 / donations / coronavirus / Vladimir Potanin
03.12.2018
Petrovax Pharm’s «Polyoxidonium» to Become the Winner of the Russian Pharma Awards
The first place in the nomination «Medicine of choice for the treatment and prevention of SARS and influenza among children» was granted to «Polyoxidonium», produced by NGO Petrovax Pharm.
More Topics Petrovax Pharm
123